Intellia Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 14, 2025 to Discuss Your Rights – NTLA — Neutral
NTLA Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Intellia Therapeutics, Inc. (NASDAQ:NTLA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/intellia-therapeutics-inc-lawsuit-submission-form?prid=129170&wire=1 or contact Joseph E. Levi, Esq.
Contact Levi & Korsinsky by April 14, 2025 Deadline to Join Class Action Against Edison Internationa l(EIX) — Neutral
EIX Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Edison International (NYSE:EIX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edison-international-lawsuit-submission-form?prid=129169&wire=1 or contact Joseph E. Levi, Esq.
Investors in Neumora Therapeutics, Inc. Should Contact Levi & Korsinsky Before April 7, 2025 to Discuss Your Rights - NMRA — Neutral
NMRA Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/neumora-therapeutics-inc-lawsuit-submission-form?prid=129172&wire=1 or contact Joseph E. Levi, Esq.
Amazon's Cloud Miss May Be Even Worse Than You Think (but It Makes Sense) — Negative
AMZN The Motley Fool — February 13, 2025Anyone keeping a close eye on Amazon (AMZN -1.65%) these days certainly already knows the company's fourth-quarter cloud computing revenue fell just short of analyst estimates, marking the second consecutive quarterly miss for its cloud arm. That disappointment paired with lackluster guidance for the quarter now underway sent shares tumbling on Friday last week, just two days after they reached a record high.
3 High-Yield Dividend Stocks I Can't Wait to Buy to Boost My Passive Income — Positive
ENB MDT VICI The Motley Fool — February 13, 2025I'm about to get a big cash infusion in my portfolio. Last year, private equity giant Blackstone agreed to buy one of my holdings, Retail Opportunity Investments Corp. , in an all-cash deal.
ESTC Investors Have Opportunity to Lead Elastic N.V. Securities Fraud Lawsuit with the Schall Law Firm — Neutral
ESTC PRNewsWire — February 13, 2025LOS ANGELES , Feb. 13, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Elastic N.V. ("Elastic" or "the Company") (NYSE: ESTC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Pinterest Shares Soar on Strong Outlook. Is It Too Late to Buy the Stock? — Positive
PINS The Motley Fool — February 13, 2025Shares of Pinterest (PINS -1.19%) soared after the social media company reported strong results and issued an upbeat forecast. This flips the script for a stock that had come under pressure its prior two quarters due to weak guidance.
Major Boeing customer Avolon sees 'impressive' progress in production following strike — Positive
BA Reuters — February 13, 2025The chief executive of major Boeing customer Avolon said on Thursday he was really encouraged by progress being made by the U.S. manufacturer in stabilising production in the wake of a seven-week strike late last year.
Gaotu Techedu to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 26, 2025 — Neutral
GOTU PRNewsWire — February 13, 2025BEIJING , Feb. 13, 2025 /PRNewswire/ -- Gaotu Techedu Inc. ("Gaotu" or the "Company") (NYSE: GOTU), a technology-driven education company and online large-class tutoring service provider in China, today announced that it will report its financial results for the fourth quarter and fiscal year 2024 ended December 31, 2024, before U.S. markets open on Wednesday, February 26, 2025. Gaotu's management will hold an earnings conference call at 8:00 AM U.S. Eastern Time on Wednesday, February 26, 2025 (9:00 PM on the same day, Beijing/Hong Kong Time).
GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit with the Schall Law Firm — Neutral
GSK PRNewsWire — February 13, 2025LOS ANGELES , Feb. 13, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GSK plc ("GSK" or "the Company") (NYSE: GSK) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 5, 2020 and August 14, 2022, inclusive (the "Class Period"), are encouraged to contact the firm before April 7, 2025.
Antengene Announces XPOVIO® Approved for Public Health Insurance Coverage in Taiwan Market, Benefiting More Patients with R/R MM in the Region — Neutral
KPTI PRNewsWire — February 13, 2025XPOVIO® is the first XPO1 inhibitor approved in Taiwan for the treatment of adult patients with relapsed/refractory multiple myeloma (R/R MM). After the mainland of China, South Korea, Australia and Singapore, Taiwan market is the fifth APAC market in which XPOVIO® has been approved for public health insurance coverage.
GLP-1 Drugs Drive Growth for Eli Lilly. Is the Stock a Buy? — Positive
LLY The Motley Fool — February 13, 2025After pre-announcing that its full-year revenue would come in below its original guidance, Eli Lilly (LLY 0.92%) announced its full results and reiterated its earlier 2025 forecast. The company has been a big beneficiary of GLP-1 drugs that have seen soaring demand as they have been shown to greatly help with multiple health issues, including weight control.
NTLA Investors Have Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm — Neutral
NTLA PRNewsWire — February 13, 2025LOS ANGELES , Feb. 13, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Intellia Therapeutics, Inc. ("Intellia" or "the Company") (NASDAQ: NTLA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 30, 2024 and January 8, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before April 14, 2025.
NMRA Investors Have Opportunity to Lead Neumora Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm — Neutral
NMRA PRNewsWire — February 13, 2025LOS ANGELES , Feb. 13, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Neumora Therapeutics, Inc. ("Neumora" or "the Company") (NASDAQ: NMRA) for violations of the federal securities laws. Investors who purchased the Company's securities pursuant and/or traceable to the Company's Offering Documents in connection with its initial public offering ("IPO") conducted on September 15, 2023, are encouraged to contact the firm before April 7, 2025.
EIX Investors Have Opportunity to Lead Edison International Securities Fraud Lawsuit with the Schall Law Firm — Neutral
EIX PRNewsWire — February 13, 2025LOS ANGELES , Feb. 13, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edison International ("Edison" or "the Company") (NYSE: EIX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 25, 2021 and February 6, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before April 14, 2025.
ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm — Neutral
ICLR PRNewsWire — February 13, 2025LOS ANGELES , Feb. 13, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company ("Icon" or "the Company") (NASDAQ: ICLR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 27, 2023 and October 23, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before April 11, 2025.
Altria's Problems Go Deeper Than Just Falling Tobacco Sales — Negative
MO The Motley Fool — February 13, 2025Smoking rates have been declining significantly for decades. According to the American Lung Association, less than 12% of adults smoked in 2022, compared to nearly 43% in 1965.
Investors who lost money on Harmonic Inc. should contact Levi & Korsinsky about an ongoing investigation - HLIT — Neutral
HLIT Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Harmonic Inc. ("Harmonic Inc.") (NASDAQ:HLIT) concerning possible violations of federal securities laws. Harmonic reported its third quarter financial results on February 10, 2025.
German cartel office warns Apple app tracking tool could violate rules — Negative
AAPL Reuters — February 13, 2025The German antitrust authority has notified Apple of concerns regarding the iPhone maker's app tracking tool, which could violate rules for large tech companies, the regulator said in a statement on Thursday.
Meet the Glorious Growth Stock Billionaire Bill Ackman Is Buying Hand Over Fist — Positive
UBER The Motley Fool — February 13, 2025Bill Ackman is the founder and CEO of Pershing Square, a hedge fund with around $12.9 billion in assets under management. That includes billions of dollars invested in popular stocks like Alphabet, Nike, and Chipotle Mexican Grill.